Polyclonal T-cell activation protocol stimulates preferential expansion of EBV-specific T-cell in vitro

Cancer Immunology, Immunotherapy

Volumn 53, Issue 5, 2004, Pages 439-444

  Hedfors, Ida Aagård ^a   Brinchmann, Jan E ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

EBV specific T cell clones; Spectra type analysis; T cell activation protocols

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2; RETROVIRUS VECTOR; VIRUS ANTIGEN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL DEATH; CELLULAR IMMUNITY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENETIC TRANSDUCTION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HERPES VIRUS; HISTOGRAM; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOSTIMULATION; IN VITRO STUDY; LEUKEMIA; LYMPHOCYTE CLONE; LYMPHOCYTOPENIA; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; SUICIDE GENE; SUICIDE GENE THERAPY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENE; APOPTOSIS; CD8+ T LYMPHOCYTE; CELL CULTURE; COMPARATIVE STUDY; GENE TRANSFER; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS CELL TRANSFORMATION;

ANTIGENS, CD28; ANTIGENS, CD3; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; GENE TRANSFER TECHNIQUES; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION;

EID: 2342462193     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-003-0462-z     Document Type: Article

References (21)

1. Algeciras-Schimnich A, Griffith TS, Lynch DH, Paya CV (1999) Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J Immunol 162:5205
2. Baum C, Dullmann J, Li Z, Fehse B, Meyer J, Williams DA, Kalle C von (2003) Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 101:2099
3. Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L, Ponzoni M, Rossini S, Mavilio F, Traversari C, Bordignon C (1997) HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276:1719
4. Collette Y, Benziane A, Razanajaona D, Olive D (1998) Distinct regulation of T-cell death by CD28 depending on both its aggregation and T-cell receptor triggering: a role for Fas-FasL. Blood 92:1350
5. Dazzi F, Goldman JM (1998) Adoptive immunotherapy following allogeneic bone marrow transplantation. Annu Rev Med 49:329-340
6. Dunne PJ, Faint JM, Gudgeon NH, Fletcher JM, Plunkett FJ, Soares MV, Hislop AD, Annels NE, Rickinson AB, Salmon M, Akba'r AN (2002) Epstein-Barr virus-specific CD8(+) T-cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. Blood 100:933
7. Grayson JM, Harrington LE, Lanier JG, Wherry EJ, Ahmed R (2002) Differential sensitivity of naive and memory CD8+ T-cells to apoptosis in vivo. J Immunol 169:3760
8. Hingorani R, Choi IH, Akolkar P, Gulwani-Akolkar B, Pergolizzi R, Silver J, Gregersen PK (1993) Clonal predominance of T-cell receptors within the CD8+ CD45RO+ subset in normal human subjects. J Immunol 151:5762
9. Inaba M, Kurasawa K, Mamura M, Kumano K, Saito Y, Iwamoto I (1999) Primed T-cells are more resistant to Fas-mediated activation-induced cell death than naive T-cells. J Immunol 163:1315
10. Kirchhoff S, Muller WW, Li-Weber M, Krammer PH (2000) Up-regulation of c-FLIP short and reduction of activation-induced cell death in CD28-costimulated human T-cells. Eur J Immunol 30:2765
11. Ku CC, Murakami M, Sakamoto A, Kappler J, Marrack P (2000) Control of homeostasis of CD8+ memory T-cells by opposing cytokines. Science 288:675
12. Lenardo MJ (1991) Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353:858
13. Mugnaini EN, Egeland T, Spurkland A, Brinchmann JE (1999) The T-cell receptor repertoire of CD8+ CD28- T lymphocytes is dominated by expanded clones that persist over time. Clin Exp Immunol 117:298
14. Mugnaini EN, Egeland T, Syversen AM, Spurkland A, Brinchmann JE (1999) Molecular analysis of the complementarity determining region 3 of the human T-cell receptor beta chain. Establishment of a reference panel of CDR3 lengths from phytohaemagglutinin-activated lymphocytes. J Immunol Methods 223:207
15. Pfeifer A, Verma IM (2001) Gene therapy: promises and problems. Annu Rev Genomics Hum Genet 2:177
16. Porter DL, Antin JH (1999) The graft-versus-leukemia effects of allogeneic cell therapy. Annu Rev Med 50:369
17. Reisaeter AV, Thorsby E, Brinchmann JE (1998) Allospecific helper T-lymphocyte repertoire in monozygotic twins. Scand J Immunol 47:381
18. Sauce D, Bodinier M, Garin M, Petracca B, Tonnelier N, Duperrier A, Melo JV, Apperley JF, Ferrand C, Herve P, Lang F, Tiberghien P, Robinet E (2002) Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection-process-dependent mechanisms. Blood 99:1165
19. Silins SL, Cross SM, Krauer KG, Moss DJ, Schmidt CW, Misko IS (1998) A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection. J Clin Invest 102:1551
20. Sullivan KM, Wingard JR, Bowden et al. (1999) Complications and their management. In: Thomas ED, Blume KG, Forman SJ (eds) Hematopoietic cell transplantasion. Blackwell, Maiden, Massachusetts, p 515
21. Zubiaga AM, Munoz E, Huber BT (1992) IL-4 and IL-2 selectively rescue Th-cell subsets from glucocorticoid-induced apoptosis. J Immunol 149:107